These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 9350967

  • 1. On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.
    Deep P, Gjedde A, Cumming P.
    J Neurosci Methods; 1997 Oct 03; 76(2):157-65. PubMed ID: 9350967
    [Abstract] [Full Text] [Related]

  • 2. Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.
    Endres CJ, DeJesus OT, Uno H, Doudet DJ, Nickles JR, Holden JE.
    Front Biosci; 2004 Jan 01; 9():505-12. PubMed ID: 14766386
    [Abstract] [Full Text] [Related]

  • 3. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
    Huang SC, Yu DC, Barrio JR, Grafton S, Melega WP, Hoffman JM, Satyamurthy N, Mazziotta JC, Phelps ME.
    J Cereb Blood Flow Metab; 1991 Nov 01; 11(6):898-913. PubMed ID: 1939385
    [Abstract] [Full Text] [Related]

  • 4. A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.
    Cumming P, Kuwabara H, Gjedde A.
    J Neurochem; 1994 Nov 01; 63(5):1675-82. PubMed ID: 7931323
    [Abstract] [Full Text] [Related]

  • 5. The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans.
    Melega WP, Hoffman JM, Luxen A, Nissenson CH, Phelps ME, Barrio JR.
    Life Sci; 1990 Nov 01; 47(2):149-57. PubMed ID: 2117691
    [Abstract] [Full Text] [Related]

  • 6. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
    Melega WP, Grafton ST, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.
    J Cereb Blood Flow Metab; 1991 Nov 01; 11(6):890-7. PubMed ID: 1939384
    [Abstract] [Full Text] [Related]

  • 7. 6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
    Barrio JR, Huang SC, Melega WP, Yu DC, Hoffman JM, Schneider JS, Satyamurthy N, Mazziotta JC, Phelps ME.
    J Neurosci Res; 1990 Dec 01; 27(4):487-93. PubMed ID: 2127807
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
    Melega WP, Luxen A, Perlmutter MM, Nissenson CH, Phelps ME, Barrio JR.
    Biochem Pharmacol; 1990 Jun 15; 39(12):1853-60. PubMed ID: 2112915
    [Abstract] [Full Text] [Related]

  • 9. 6-fluoroDOPA metabolism in rat striatum: time course of extracellular metabolites.
    DeJesus OT, Haaparanta M, Solin O, Nickles RJ.
    Brain Res; 2000 Sep 15; 877(1):31-6. PubMed ID: 10980240
    [Abstract] [Full Text] [Related]

  • 10. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
    Kumakura Y, Vernaleken I, Gründer G, Bartenstein P, Gjedde A, Cumming P.
    J Cereb Blood Flow Metab; 2005 Jul 15; 25(7):807-19. PubMed ID: 15729292
    [Abstract] [Full Text] [Related]

  • 11. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
    Danielsen EH, Smith DF, Gee AD, Venkatachalam TK, Hansen SB, Hermansen F, Gjedde A, Cumming P.
    Synapse; 1999 Sep 15; 33(4):247-58. PubMed ID: 10421705
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
    Cumming P, Léger GC, Kuwabara H, Gjedde A.
    J Cereb Blood Flow Metab; 1993 Jul 15; 13(4):668-75. PubMed ID: 8314919
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
    Ishiwata K, Shinoda M, Ishii S, Nozaki T, Senda M.
    Nucl Med Biol; 1996 Apr 15; 23(3):295-301. PubMed ID: 8782240
    [Abstract] [Full Text] [Related]

  • 14. 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism and positron emission tomography after catechol-O-methyltransferase inhibition in normal and hemiparkinsonian monkeys.
    Miletich RS, Comi G, Bankiewicz K, Plunkett R, Adams R, Di Chiro G, Kopin IJ.
    Brain Res; 1993 Oct 29; 626(1-2):1-13. PubMed ID: 8281420
    [Abstract] [Full Text] [Related]

  • 15. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
    Ishikawa T, Dhawan V, Chaly T, Robeson W, Belakhlef A, Mandel F, Dahl R, Margouleff C, Eidelberg D.
    J Cereb Blood Flow Metab; 1996 Sep 29; 16(5):854-63. PubMed ID: 8784230
    [Abstract] [Full Text] [Related]

  • 16. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study.
    Kumakura Y, Cumming P, Vernaleken I, Buchholz HG, Siessmeier T, Heinz A, Kienast T, Bartenstein P, Gründer G.
    J Neurosci; 2007 Jul 25; 27(30):8080-7. PubMed ID: 17652599
    [Abstract] [Full Text] [Related]

  • 17. The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study.
    Brust P, Vorwieger G, Walter B, Füchtner F, Stark H, Kuwabara H, Herzau M, Opfermann T, Steinbach J, Ganapathy V, Bauer R.
    Brain Res Dev Brain Res; 2004 Sep 17; 152(2):241-53. PubMed ID: 15351512
    [Abstract] [Full Text] [Related]

  • 18. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
    Cumming P, Ase A, Diksic M, Harrison J, Jolly D, Kuwabara H, Laliberté C, Gjedde A.
    Biochem Pharmacol; 1995 Sep 28; 50(7):943-6. PubMed ID: 7575677
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous measurement of [18F]FDOPA metabolism and cerebral blood flow in newborn piglets.
    Brust P, Bauer R, Walter B, Bergmann R, Füchtner F, Vorwieger G, Steinbach J, Johannsen B, Zwiener U.
    Int J Dev Neurosci; 1998 Aug 28; 16(5):353-64. PubMed ID: 9829172
    [Abstract] [Full Text] [Related]

  • 20. [Fluorine-18 labeled 6-fluoro-L-dopa: systematization and evaluation of its usefulness].
    Fujii R, Imahori Y, Kimura M, Toyama K, Yuasa M, Kumakura Y, Horii H, Wakita K, Yagyu T, Nakamura T, Ido T, Ueda S, Kanatsuna T.
    Kaku Igaku; 1997 Nov 28; 34(11):1055-61. PubMed ID: 9455047
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.